Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies.
about
Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus.Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian amazon region.Naturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro.Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparumAntibodies to a conserved-motif peptide sequence of the Plasmodium falciparum thrombospondin-related anonymous protein and circumsporozoite protein recognize a 78-kilodalton protein in the asexual blood stages of the parasite and inhibit merozoite iComparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.Development of cowpea mosaic virus-based vectors for the production of vaccines in plants.Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stagesRecombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum.Plasmodium chabaudi antigen Pch105, Plasmodium falciparum antigen Pf155, and erythrocyte band 3 share cross-reactive epitopesParasitic infection and autoimmunity.Recent advances in the development of a chemically synthesised anti-malarial vaccine.An update on candidate malaria vaccines.Mechanisms of immunity to malaria and the possibilities of a blood-stage vaccine: a critical appraisal.A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission.Opsonization and phagocytosis of Plasmodium falciparum merozoites measured by flow cytometry.In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection.Specific T-cell recognition of the merozoite proteins rhoptry-associated protein 1 and erythrocyte-binding antigen 1 of Plasmodium falciparum.Conservation of antigen components from two recombinant hybrid proteins protective against malaria.Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.Major surface antigen p190 of Plasmodium falciparum: detection of common epitopes present in a variety of plasmodia isolates.A naturally occurring gene encoding the major surface antigen precursor p190 of Plasmodium falciparum lacks tripeptide repeats.A rhoptry antigen of Plasmodium falciparum is protective in Saimiri monkeys.A hybrid gene to express protein epitopes from both sporozoite and merozoite surface antigens of Plasmodium falciparum.Immunization against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli.Cytoadherence-related homologous motifs in Plasmodium falciparum antigen Pf155/RESA and erythrocyte band 3 protein.Malaria diagnosis: memorandum from a WHO meeting
P2860
Q33605280-C9746023-82A1-4E00-A116-18C30E1978F3Q34002481-FBDAD83F-9877-48D7-B4A5-CC4EE8E1F02EQ34541366-1275E4C6-DCED-4FFC-AF72-2A8C1671AF38Q35383761-622A5CC3-017E-429F-9C6E-46189A1EA7E2Q35498349-47E00329-AA6E-4781-B84C-50A644F80D6CQ35551948-CD8EFAA4-76C8-429A-8925-AD358E4A7595Q36284554-BBB27D11-7C40-44E4-A79B-7B91EEB1FC79Q36354328-2A8FFBC2-2EAB-422B-91DE-D46D8F9A1566Q36404193-4596081A-165A-4FCD-9779-CCF5C20612D3Q36943106-D9761565-D3B2-485F-A030-47795F84A4F7Q36996812-3502B37D-8BDA-472A-AB69-7382BB30B9AEQ37526320-B570B142-3965-4B3C-8D02-B522C15FC58DQ38560128-A9F889C8-B54E-4C23-B4E3-9BDF5F622E4AQ38635546-8D59D082-EADC-4FA0-A89E-5E707B69FADAQ38674929-58A0AF02-DDD0-463F-AAA8-3D6AC466DBC5Q39387268-AC8A17E4-9C9B-4D56-943A-EF14378BDEBBQ39506840-D76A72E1-5B34-4408-BDF3-6D6DD4CA0DFCQ39655089-62FFE898-51B9-4ADA-81A7-ADB8CCB80AAFQ40148558-364352FC-6631-41FE-834B-3A188AC2CD6BQ40373716-C4486C4B-3151-4B64-B558-4EDFB0DC878AQ40374219-3AD47B24-C60F-44CA-AC81-122548D154F2Q40734085-0E3ED061-712B-43F8-9BE4-5248A9EA3276Q41090784-6D0091EC-3BD1-4FD5-ADA1-1ED8E925532CQ41360467-8831FB23-EF89-45CB-89BA-E79CB9D0D485Q46186627-F85D7DBE-DCF7-4F12-A61A-86166509311AQ47888235-F39334CF-8D7B-47F4-8449-62C516E9F08CQ47905693-86F9A8CD-78D3-476E-84D3-97F9174F1BA9Q48000947-90D4590E-16BF-4AC2-8E75-A575DA58E65AQ57954052-3D7284F3-8508-4F12-9502-DA240B0EAE9E
P2860
Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Immunization with synthetic pe ...... uces antimerozoite antibodies.
@en
Immunization with synthetic pe ...... uces antimerozoite antibodies.
@nl
type
label
Immunization with synthetic pe ...... uces antimerozoite antibodies.
@en
Immunization with synthetic pe ...... uces antimerozoite antibodies.
@nl
prefLabel
Immunization with synthetic pe ...... uces antimerozoite antibodies.
@en
Immunization with synthetic pe ...... uces antimerozoite antibodies.
@nl
P2093
P2860
P921
P356
P1476
Immunization with synthetic pe ...... uces antimerozoite antibodies.
@en
P2093
Chizzolini C
P2860
P304
P356
10.1073/PNAS.83.21.8328
P407
P577
1986-11-01T00:00:00Z